To survive in the human host, bacteria have developed many different strategies to escape the innate immune response, including the expression of an extracellular capsule and 'hiding' within host ...

Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy Paris, June 10, 2026. Sanofi today announced that the riliprubart MOBILIZE phase ...

Shares of Dianthus Therapeutics (DNTH) fell more than 20% in the premarket on Wednesday after efficacy concerns prompted Sanofi (SNY) to halt a late-stage trial of riliprubart, an experimental therapy ...

Sanofi (NASDAQ:SNY) said on Wednesday that it has decided to discontinue the phase 3 MOBILIZE trial evaluating riliprubart in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) who ...

The BBC is bringing audiences an unmissable summer of music in 2026, featuring live performances from some of the world’s ...

Get inspired to makeover your living spaces this year with these 100 incredible before and after home projects.

Time to get your systems in order, Aquarius. With the Sun in Cancer and your sixth house of health and routines until July 22—and Mercury retrograde here until the 23rd—you’ll be fine-tuning ...

The South Carolina Botanical Garden proves that nature education can be super fun. This garden has different areas showcasing ...

The human complement system has a pivotal role in the recognition, opsonization and elimination of microbial intruders. This functionality is maintained by a well-balanced interaction network of serum ...

Travere Therapeutics has transitioned into a rare disease commercial platform, driven by FILSPARI’s growth in IgAN and recent FSGS approval. More on TVTX stock.